Serveur d'exploration Tocilizumab - Curation (PubMed)

Index « Auteurs » - entrée « Kiyoshi Migita »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Kiyoshi Matsui < Kiyoshi Migita < Kiyoshi Misawa  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000122 (2020) Jumpei Temmoku [Japon] ; Yuya Fujita [Japon] ; Naoki Matsuoka [Japon] ; Takeshi Urano [Japon] ; Makiko Yashiro Furuya [Japon] ; Tomoyuki Asano [Japon] ; Shuzo Sato [Japon] ; Haruki Matsumoto [Japon] ; Hiroshi Watanabe [Japon] ; Hideko Kozuru [Japon] ; Hiroshi Yatsuhashi [Japon] ; Atsushi Kawakami [Japon] ; Kiyoshi Migita [Japon]Uric acid-mediated inflammasome activation in IL-6 primed innate immune cells is regulated by baricitinib.
000162 (2020) Tomoyuki Asano ; Shuzo Sato ; Jumpei Temmoku ; Yuya Fujita ; Makiko Yashiro Furuya ; Naoki Matsuoka ; Hiroko Kobayashi ; Eiji Suzuki [Japon] ; Hiroshi Watanabe ; Kiyoshi MigitaEffectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports.
000428 (2019) Tetsuro Yokokawa [Japon] ; Hiroyuki Kunii [Japon] ; Takashi Kaneshiro [Japon] ; Shohei Ichimura [Japon] ; Akiomi Yoshihisa [Japon] ; Makiko Yashiro Furuya [Japon] ; Tomoyuki Asano [Japon] ; Kazuhiko Nakazato [Japon] ; Takafumi Ishida [Japon] ; Kiyoshi Migita [Japon] ; Yasuchika Takeishi [Japon]Regressed coronary ostial stenosis in a young female with Takayasu arteritis: a case report.
000760 (2018) Tomoyuki Asano [Japon] ; Makiko Yashiro Furuya [Japon] ; Shuzo Sato [Japon] ; Hiroko Kobayashi [Japon] ; Hiroshi Watanabe [Japon] ; Eiji Suzuki [Japon] ; Kiyoshi Migita [Japon]Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still's disease.
000A36 (????) Junko Yabuuchi [Japon] ; Noriko Hayami [Japon] ; Junichi Hoshino [Japon] ; Keiichi Sumida [Japon] ; Tatsuya Suwabe [Japon] ; Toshiharu Ueno [Japon] ; Akinari Sekine [Japon] ; Masahiro Kawada [Japon] ; Masayuki Yamanouchi [Japon] ; Rikako Hiramatsu [Japon] ; Eiko Hasegawa [Japon] ; Naoki Sawa [Japon] ; Kenmei Takaichi [Japon] ; Takeshi Fujii [Japon] ; Kenichi Ohashi [Japon] ; Kiyoshi Migita [Japon] ; Takao Masaki [Japon] ; Yoshifumi Ubara [Japon]AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations.
000E05 (????) Shin-Ya Kawashiri [Japon] ; Ayako Nishino [Japon] ; Takahisa Suzuki [Japon] ; Yoshikazu Nakashima [Japon] ; Yoshiro Horai [Japon] ; Yukitaka Ueki [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Munetoshi Nakashima [Japon] ; Akitomo Okada [Japon] ; Kiyoshi Migita [Japon] ; Akinari Mizokami [Japon] ; Naoki Matsuoka [Japon] ; Masanobu Mine [Japon] ; Soko Sakito [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Kiyoshi Aoyagi [Japon] ; Katsumi Eguchi [Japon] ; Atsushi Kawakami [Japon]Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
000E81 (2016) Shinichiro Tsurukawa [Japon] ; Nozomi Iwanaga [Japon] ; Yasumori Izumi [Japon] ; Atsunori Shirakawa [Japon] ; Chieko Kawahara [Japon] ; Tetsuo Shukuwa [Japon] ; Miwako Inamoto [Japon] ; Atsushi Kawakami [Japon] ; Kiyoshi Migita [Japon]Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still's Disease.
000F27 (2016) Tomohiro Koga ; Kiyoshi Migita ; Atsushi KawakamiBiologic therapy in familial Mediterranean fever.
001034 (2017) Masataka Umeda [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Kaoru Terada [Japon] ; Gou Takeo [Japon] ; Nobuhisa Yonemitsu [Japon] ; Yukitaka Ueki [Japon] ; Kiyoshi Migita [Japon] ; Atsushi Kawakami [Japon]Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis.
001169 (2015) Ryoko Sakai [Japon] ; Soo-Kyung Cho [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Michi Tanaka [Japon] ; Ryuji Koike [Japon] ; Yoshiya Tanaka [Japon] ; Kazuyoshi Saito [Japon] ; Shintaro Hirata [Japon] ; Koichi Amano [Japon] ; Hayato Nagasawa [Japon] ; Takayuki Sumida [Japon] ; Taichi Hayashi [Japon] ; Takahiko Sugihara [Japon] ; Hiroaki Dobashi [Japon] ; Shinsuke Yasuda [Japon] ; Tetsuji Sawada [Japon] ; Kazuhiko Ezawa [Japon] ; Atsuhisa Ueda [Japon] ; Takao Fujii [Japon] ; Kiyoshi Migita [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry.
001565 (????) Keita Fujikawa [Japon] ; Kiyoshi Migita ; Toshiaki Tsukada ; Masataka Umeda ; Fumiaki Nonaka ; Atsushi Kawakami ; Katsumi EguchiInterleukin-6 targeting therapy in familial Mediterranean fever.
001A85 (2011) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami ; Naoki Iwamoto ; Keita Fujikawa ; Toshiyuki Aramaki ; Mami Tamai ; Satoshi Yamasaki ; Hideki Nakamura ; Tomoki Origuchi ; Yukitaka Ueki ; Kiyoshi Migita ; Akinari Mizokami ; Kiyoshi Aoyagi ; Katsumi EguchiIn rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline.
001A91 (2011) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami ; Naoki Iwamoto ; Keita Fujikawa ; Toshiyuki Aramaki ; Mami Tamai ; Satoshi Yamasaki ; Hideki Nakamura ; Yukitaka Ueki ; Kiyoshi Migita ; Akinari Mizokami ; Tomoki Origuchi ; Kiyoshi Aoyagi ; Katsumi EguchiDisease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Kiyoshi Migita" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Kiyoshi Migita" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Kiyoshi Migita
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021